In June 2025, Amgen reported robust results from its Phase2 clinical study of MariTide, a monthly injectable bispecific GLP-1/GIP receptor agonist
Whilst these medications have demonstrated significant efficacy in glycaemic control and weight reduction, their potential role in addressing disordered eating patterns, including binge eating, has emerged as an area of clinical and research interest
Similarly, tirzepatide injection timing has nuances worth understanding before building your schedule
Understanding your medication's specific timeline helps your surgical team plan appropriate safeguards
Ethanol exacerbates manganese-induced functional alterations along the hypothalamicpituitarygonadal axis of male rats
The concern over compounded GLP-1s Typically, compounding pharmacies are not allowed to make copies of FDA-approved medications